India's #pharma sector is expected to grow at 9-11 per cent in FY22, rating agency ICRA said on Tuesday.
It attributed the growth to the improving demand for non-Covid products in addition to new product introductions, #rupee depreciation, and expanding market coverage. pic.twitter.com/h6WysfFF6p— IANS Tweets (@ians_india) January 4, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


